Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WEANLESS: Levosimendan for Weaning From Invasive Ventilation
NCT07105202Phase 4Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levosimendan in Weaning failure, sponsored by Radboud University Medical Center. Started Sep 2025; status: recruiting.
02
Drugs
levosimendan
03
Conditions
Weaning failure
Beyond the preview
Go deeper on NCT07105202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07105202.